|
| Status |
Public on Mar 20, 2023 |
| Title |
Opioid agonists as potential AML therapy |
| Organism |
Homo sapiens |
| Experiment type |
Methylation profiling by high throughput sequencing
Expression profiling by high throughput sequencing
|
| Summary |
This SuperSeries is composed of the SubSeries listed below.
|
| |
|
| Overall design |
Refer to individual Series
|
| |
|
| Citation missing |
Has this study been published? Please login to update or notify GEO. |
| Submission date |
Mar 25, 2020 |
| Last update date |
Mar 20, 2023 |
| Contact name |
Jun Lu |
| E-mail(s) |
lujun4726@zju.edu.cn
|
| Phone |
18258826247
|
| Organization name |
Zhejiang University
|
| Street address |
866 Yuhangtang Road
|
| City |
Hangzhou |
| State/province |
Zhejiang |
| ZIP/Postal code |
3100058 |
| Country |
China |
| |
|
| Platforms (1) |
| GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
| Samples (6)
|
|
| This SuperSeries is composed of the following SubSeries: |
| GSE147509 |
Opioid receptor signaling suppresses leukemia by inducing TET-dependent DNA demethylation [5hmC-seq] |
| GSE147510 |
Opioid receptor signaling suppresses leukemia by inducing TET-dependent DNA demethylation [RNA-seq] |
|
| Relations |
| BioProject |
PRJNA615085 |
Less...
More...